{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T17:10:12Z","timestamp":1731258612777,"version":"3.28.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,10]]},"DOI":"10.7759\/cureus.73382","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T16:54:21Z","timestamp":1731257661000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors and Impact on Survival of Pathological Fractures in Patients With Humeral Metastasis"],"prefix":"10.7759","author":[{"given":"Shiro","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisaki","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22991","article-title":"Pathologic fractures correlate with reduced survival in patients with malignant bone disease","volume":"110","author":"Saad F","year":"2007","unstructured":"Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 2007, 110:1860-7. 10.1002\/cncr.22991","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-198912000-00027","article-title":"Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures","volume":"249","author":"Mirels H","year":"1989","unstructured":"Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989, 249:256-64. 10.1097\/00003086-198912000-00027","journal-title":"Clin Orthop Relat Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153662","article-title":"Fracture risk of long bone metastases: a review of current and new decision-making tools for prophylactic surgery","volume":"13","author":"Nguy\u1ec5n MV","year":"2021","unstructured":"Nguy\u1ec5n MV, Carlier C, Nich C, Gouin F, Crenn V. Fracture risk of long bone metastases: a review of current and new decision-making tools for prophylactic surgery. Cancers (Basel). 2021, 13:3662. 10.3390\/cancers13153662","journal-title":"Cancers (Basel)"},{"key":"ref4","article-title":"Comparative analysis of risk factors for pathological fracture with femoral metastases","volume":"86","author":"Van der Linden YM","year":"2004","unstructured":"Van der Linden YM, Dijkstra PD, Kroon HM, Lok JJ, Noordijk EM, Leer JW, Marijnen CA. Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br. 2004, 86:566-73.","journal-title":"J Bone Joint Surg Br"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/CORR.0000000000000803","article-title":"Is there an association between prophylactic femur stabilization and survival in patients with metastatic bone disease?","volume":"478","author":"Philipp TC","year":"2020","unstructured":"Philipp TC, Mikula JD, Doung YC, Gundle KR. Is there an association between prophylactic femur stabilization and survival in patients with metastatic bone disease?. Clin Orthop Relat Res. 2020, 478:540-6. 10.1097\/CORR.0000000000000803","journal-title":"Clin Orthop Relat Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0107","article-title":"Ambulation recovery after surgery for metastases to the femur","volume":"25","author":"Kim Y","year":"2020","unstructured":"Kim Y, Krishnan CK, Kim HS, Cho HS, Han I. Ambulation recovery after surgery for metastases to the femur. Oncologist. 2020, 25:e178-85. 10.1634\/theoncologist.2019-0107","journal-title":"Oncologist"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/os.12393","article-title":"Is ambulatory status a prognostic factor of survival in patients with spinal metastases? An exploratory meta-analysis","volume":"10","author":"Yang XG","year":"2018","unstructured":"Yang XG, Han Y, Wang F, et al.. Is ambulatory status a prognostic factor of survival in patients with spinal metastases? An exploratory meta-analysis. Orthop Surg. 2018, 10:173-80. 10.1111\/os.12393","journal-title":"Orthop Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-8140(03)00232-9","article-title":"Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomised trial","volume":"69","author":"Van der Linden YM","year":"2003","unstructured":"Van der Linden YM, Kroon HM, Dijkstra SPDS, Lok JJ, Noordijka EM, Leere JWH, Marijnena CAM. Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomised trial. Radiother Oncol. 2003, 69:21-31. 10.1016\/s0167-8140(03)00232-9","journal-title":"Radiother Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda Y","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013, 48:452-8. 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.blo.0000093052.96273.a7","article-title":"Evaluation and treatment of metastases to the humerus","volume":"415","author":"Frassica FJ","year":"2003","unstructured":"Frassica FJ, Frassica DA. Evaluation and treatment of metastases to the humerus. Clin Orthop Relat Res. 2003, 415:S212-8. 10.1097\/01.blo.0000093052.96273.a7","journal-title":"Clin Orthop Relat Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2010.09.018","article-title":"Protocol of surgical treatment of long bone pathological fractures","volume":"41","author":"Ruggieri P","year":"2010","unstructured":"Ruggieri P, Mavrogenis AF, Casadei R, et al.. Protocol of surgical treatment of long bone pathological fractures. Injury. 2010, 41:1161-7. 10.1016\/j.injury.2010.09.018","journal-title":"Injury"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jseint.2022.03.006","article-title":"Mirels' score for upper limb metastatic lesions: do we need a different cutoff for recommending prophylactic fixation?","volume":"6","author":"Hoban KA","year":"2022","unstructured":"Hoban KA, Downie S, Adamson DJ, MacLean JG, Cool P, Jariwala AC. Mirels' score for upper limb metastatic lesions: do we need a different cutoff for recommending prophylactic fixation?. JSES Int. 2022, 6:675-81. 10.1016\/j.jseint.2022.03.006","journal-title":"JSES Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck AT","year":"2010","unstructured":"Stopeck AT, Lipton A, Body JJ, et al.. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol. 2010, 28:5132-9. 10.1200\/JCO.2010.29.7101","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi K","year":"2011","unstructured":"Fizazi K, Carducci M, Smith M, et al.. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet. 2011, 377:813-22. 10.1016\/S0140-6736(10)62344-6","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry DH","year":"2011","unstructured":"Henry DH, Costa L, Goldwasser F, et al.. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol. 2011, 29:1125-32. 10.1200\/JCO.2010.31.3304","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study","volume":"19","author":"Raje N","year":"2018","unstructured":"Raje N, Terpos E, Willenbacher W, Shimizu K, Garc\u00eda-Sanz R, Durie B. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol. 2018, 19:370-81. 10.1016\/S1470-2045(18)30072-X","journal-title":"Lancet Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.5635","article-title":"Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression","volume":"28","author":"Rades D","year":"2010","unstructured":"Rades D, Huttenlocher S, Dunst J, Bajrovic A, Karstens JH, Rudat V, Schild SE. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. J Clin Oncol. 2010, 28:3597-604. 10.1200\/JCO.2010.28.5635","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-014-0227-1","article-title":"Assessment of the risk factors for impending fractures following radiotherapy for long bone metastases using CT scan-based virtual simulation: a retrospective study","volume":"9","author":"Tatar Z","year":"2014","unstructured":"Tatar Z, Soubrier M, Dillies AF, Verrelle P, Boisgard S, Lapeyre M. Assessment of the risk factors for impending fractures following radiotherapy for long bone metastases using CT scan-based virtual simulation: a retrospective study. Radiat Oncol. 2014, 9:227. 10.1186\/s13014-014-0227-1","journal-title":"Radiat Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2018.09.007","article-title":"Prognostic and risk factors in patients with metastatic bone disease of an upper extremity","volume":"13","author":"Wisanuyotin T","year":"2018","unstructured":"Wisanuyotin T, Sirichativapee W, Sumnanoont C, Paholpak P, Laupattarakasem P, Sukhonthamarn K, Kosuwon W. Prognostic and risk factors in patients with metastatic bone disease of an upper extremity. J Bone Oncol. 2018, 13:71-5. 10.1016\/j.jbo.2018.09.007","journal-title":"J Bone Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jse.2011.06.019","article-title":"Complications and survival after surgical treatment of 214 metastatic lesions of the humerus","volume":"21","author":"Wedin R","year":"2012","unstructured":"Wedin R, Hansen BH, Laitinen M, et al.. Complications and survival after surgical treatment of 214 metastatic lesions of the humerus. J Shoulder Elbow Surg. 2012, 21:1049-55. 10.1016\/j.jse.2011.06.019","journal-title":"J Shoulder Elbow Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13788","article-title":"Intramedullary nailing versus plate osteosynthesis for humeral shaft metastatic lesions","volume":"13","author":"Ricard MM","year":"2021","unstructured":"Ricard MM, Stavropoulos NA, Nooh A, Ste-Marie N, Goulding K, Turcotte R. Intramedullary nailing versus plate osteosynthesis for humeral shaft metastatic lesions. Cureus. 2021, 13:e13788. 10.7759\/cureus.13788","journal-title":"Cureus"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202211_30288","article-title":"Proximal humerus fractures treatment in adult patients with bone metastasis","volume":"26","author":"Rovere G","year":"2022","unstructured":"Rovere G, Meschini C, Piazza P, et al.. Proximal humerus fractures treatment in adult patients with bone metastasis. Eur Rev Med Pharmacol Sci. 2022, 26:100-5. 10.26355\/eurrev_202211_30288","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/309245-risk-factors-and-impact-on-survival-of-pathological-fractures-in-patients-with-humeral-metastasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T16:54:23Z","timestamp":1731257663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/309245-risk-factors-and-impact-on-survival-of-pathological-fractures-in-patients-with-humeral-metastasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,10]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.73382","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,10]]}}}